BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 29228657)

  • 1. Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies.
    Khalaf N; Yuan C; Hamada T; Cao Y; Babic A; Morales-Oyarvide V; Kraft P; Ng K; Giovannucci E; Ogino S; Stampfer M; Cochrane BB; Manson JE; Clish CB; Chan AT; Fuchs CS; Wolpin BM
    Gastroenterology; 2018 Apr; 154(5):1380-1390.e5. PubMed ID: 29229401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer of the Liver and its Relationship with Diabetes mellitus.
    Onikanni SA; Lawal B; Bakare OS; Ajiboye BO; Ojo OA; Farasani A; Kabrah SM; Batiha GE; Conte-Junior CA
    Technol Cancer Res Treat; 2022; 21():15330338221119743. PubMed ID: 36533882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-Glucosidase Inhibitor Voglibose Suppresses Azoxymethane-Induced Colonic Preneoplastic Lesions in Diabetic and Obese Mice.
    Kato J; Shirakami Y; Mizutani T; Kubota M; Sakai H; Ibuka T; Shimizu M
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AGA Clinical Practice Update on Chemoprevention for Colorectal Neoplasia: Expert Review.
    Liang PS; Shaukat A; Crockett SD
    Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1327-1336. PubMed ID: 33581359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries.
    Mo C; Sun G; Lu ML; Zhang L; Wang YZ; Sun X; Yang YS
    World J Gastroenterol; 2015 May; 21(17):5382-92. PubMed ID: 25954113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-glucosidase inhibitor use is associated with decreased colorectal neoplasia risk in patients with type 2 diabetes mellitus receiving colonoscopy: a retrospective study.
    Horibe Y; Adachi S; Ohno T; Goto N; Okuno M; Iwama M; Yamauchi O; Kojima T; Saito K; Ibuka T; Yasuda I; Araki H; Moriwaki H; Shimizu M
    Oncotarget; 2017 Nov; 8(58):97862-97870. PubMed ID: 29228657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of aspirin, statins and ACE-inhibitors on the presentation of colorectal neoplasia in a colorectal cancer screening programme.
    Mansouri D; McMillan DC; Roxburgh CS; Crighton EM; Horgan PG
    Br J Cancer; 2013 Jul; 109(1):249-56. PubMed ID: 23778525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use.
    Siersema PD; Yu S; Sahbaie P; Steyerberg EW; Simpson PW; Kuipers EJ; Triadafilopoulos G
    Gastrointest Endosc; 2006 Apr; 63(4):581-6. PubMed ID: 16564855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Colorectal Neoplasia in Individuals With Self-Reported Family History: A Prospective Colonoscopy Study from 16 Asia-Pacific Regions.
    Wong MC; Ching JY; Chiu HM; Wu KC; Rerknimitr R; Li J; Wu DC; Goh KL; Matsuda T; Kim HS; Leong R; Yeoh KG; Chong VH; Sollano JD; Ahmed F; Menon J; Ng SC; Wu JC; Chan FK; Sung JJ
    Am J Gastroenterol; 2016 Nov; 111(11):1621-1629. PubMed ID: 26977757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 diabetes mellitus and colorectal neoplasia risk in Hispanics: a case-control study.
    Díaz-Algorri Y; Lozada ME; López SM; Bertrán-Rodríguez CE; González-Hernández CM; González D; Pérez-Cardona CM; Hernández J; Pedrosa C; Toro DH; González-Pons M; Cruz-Correa M
    J Diabetes Complications; 2015; 29(4):502-7. PubMed ID: 25784088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan.
    Nadatani Y; Watanabe T; Tanigawa T; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Yoshiyama M; Arakawa T
    Scand J Gastroenterol; 2013 Mar; 48(3):320-5. PubMed ID: 23298342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Novel Scoring System for Predicting the Risk of Colorectal Neoplasia: A Retrospective Study.
    Ohno T; Adachi S; Okuno M; Horibe Y; Goto N; Iwama M; Yamauchi O; Kojima T; Saito K; Ibuka T; Yasuda I; Araki H; Moriwaki H; Shimizu M
    PLoS One; 2016; 11(6):e0157269. PubMed ID: 27284907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension, serum lipids and cancer risk: A review of epidemiological evidence.
    Radišauskas R; Kuzmickienė I; Milinavičienė E; Everatt R
    Medicina (Kaunas); 2016; 52(2):89-98. PubMed ID: 27170481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disentangling the Association between Statins, Cholesterol, and Colorectal Cancer: A Nested Case-Control Study.
    Mamtani R; Lewis JD; Scott FI; Ahmad T; Goldberg DS; Datta J; Yang YX; Boursi B
    PLoS Med; 2016 Apr; 13(4):e1002007. PubMed ID: 27116322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin use and the risk of colorectal adenoma: A meta-analysis.
    Jung YS; Park CH; Eun CS; Park DI; Han DS
    J Gastroenterol Hepatol; 2016 Nov; 31(11):1823-1830. PubMed ID: 27043957
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.